Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sachse

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
AAPS Pharmsci|December 14, 2001
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial settingS McElroy, C Sachse, J Brockmoller, et al.
Psychopharmacology|October 21, 2000
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatientsM Dettling, C Sachse, J Brockmöller, et al.
Rheumatology International|April 25, 2000
Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study groupT Witte, K Hartung, C Sachse, et al.
Rheumatology International|January 1, 1995
Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study GroupC Sachse, K Lüthke, K Hartung, et al.
Rheumatology International|October 23, 1998
Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study GroupT Witte, K Hartung, T Matthias, et al.
Rheumatology International|January 29, 2000
Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parametersT Witte, K Hartung, C Sachse, et al.
Rheumatology International|December 2, 1998
IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study GroupT Witte, K Hartung, C Sachse, et al.
Clinical Pharmacology and Therapeutics|September 8, 2015
Heritability of metoprolol and torsemide pharmacokineticsJ Matthaei, J Brockmöller, M V Tzvetkov, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylationK J Aitchison, J Munro, P Wright, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
AAPS Pharmsci|December 14, 2001
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial settingS McElroy, C Sachse, J Brockmoller, et al.
Psychopharmacology|October 21, 2000
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatientsM Dettling, C Sachse, J Brockmöller, et al.
Rheumatology International|April 25, 2000
Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study groupT Witte, K Hartung, C Sachse, et al.
Rheumatology International|January 1, 1995
Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study GroupC Sachse, K Lüthke, K Hartung, et al.
Rheumatology International|October 23, 1998
Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study GroupT Witte, K Hartung, T Matthias, et al.
Rheumatology International|January 29, 2000
Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parametersT Witte, K Hartung, C Sachse, et al.
Rheumatology International|December 2, 1998
IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study GroupT Witte, K Hartung, C Sachse, et al.
Clinical Pharmacology and Therapeutics|September 8, 2015
Heritability of metoprolol and torsemide pharmacokineticsJ Matthaei, J Brockmöller, M V Tzvetkov, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylationK J Aitchison, J Munro, P Wright, et al.
Pageof 5